findmyKOL

Murtuza Ali, MD

Basic profile

Louisiana State University Health Sciences Center New Orleans

ORCIDNone on fileNPI
RegionNew Orleans, LA · South CentralSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Murtuza Ali is a Cardiology physician affiliated with Louisiana State University Health Sciences Center New Orleans. OpenAlex indexes 47 publications with 351 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
47publications

Distinct works indexed by OpenAlex.

351citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
26companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2021 Perdido St
New Orleans, LA 701121352

Telephone

504-412-1835

Registry record last updated 20 Jan 2010.

View the NPPES registry record

Industry payments

26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.5%
    Beta blocker19.6%
    Carvedilol42%Metoprolol Succinate34%Labetalol Hcl13%Metoprolol Tartrate12%
    Part D<11 patients
    Statin17.7%
    Atorvastatin Calcium66%Rosuvastatin Calcium34%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    8.2%
    Factor Xa inhibitor5.9%
    Eliquis100%
    Part D13 patients
    P2Y12 inhibitor2.3%
    Clopidogrel100%
    Part D<11 patients
  • Genitourinary & hormones

    2.3%
    alpha-Adrenergic Blocker2.3%
    Tamsulosin Hcl100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”